BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7684340)

  • 1. The modulation of placental lactogen release by opioids: a role for extracellular calcium.
    Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Bélisle S
    Mol Cell Endocrinol; 1993 Jan; 90(2):165-70. PubMed ID: 7684340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for extracellular calcium in the regulation of placental lactogen release by angiotensin-II and dopamine in human term trophoblastic cells.
    Petit A; Gallo-Payet N; Vaillancourt C; Bellabarba D; Lehoux JG; Bélisle S
    J Clin Endocrinol Metab; 1993 Sep; 77(3):670-6. PubMed ID: 7690361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 3':5'-cyclic monophosphate (cAMP) is not the mediator of kappa opiate effect on human placental lactogen release.
    Petit A; Gallo-Payet N; Lehoux JG; Bellabarba D; Bélisle S
    Life Sci; 1991; 49(6):465-72. PubMed ID: 1650874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells.
    Jin W; Lee NM; Loh HH; Thayer SA
    J Neurosci; 1994 Apr; 14(4):1920-9. PubMed ID: 8158247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
    Jin W; Lee NM; Loh HH; Thayer SA
    Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
    Evans RG; Ludbrook J; Van Leeuwen AF
    J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different G proteins mediate the opioid inhibition or enhancement of evoked [5-methionine]enkephalin release.
    Gintzler AR; Xu H
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4741-5. PubMed ID: 1828885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids modify the release of LH at the pituitary level: in vitro studies with entire rat pituitaries.
    Dragatsis I; Papazafiri P; Zioudrou C; Gerozissis K
    J Endocrinol; 1995 May; 145(2):263-70. PubMed ID: 7616159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opiate agonists inhibit Ca2+ influx in rat spinal cord-dorsal root ganglion cocultures. Involvement of a GTP-binding protein.
    Attali B; Saya D; Nah SY; Vogel Z
    J Biol Chem; 1989 Jan; 264(1):347-53. PubMed ID: 2535841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid agonists modulate release of neurotransmitters in bovine trachealis muscle.
    Zappi L; Nicosia F; Rocchi D; Song P; Rehder K
    Anesthesiology; 1995 Sep; 83(3):543-51. PubMed ID: 7661355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid actions on neurons of rat lateral amygdala in vitro.
    Sugita S; North RA
    Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels.
    Kojima Y; Takahashi T; Fujina M; Owyang C
    J Pharmacol Exp Ther; 1994 Feb; 268(2):965-70. PubMed ID: 8114012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nor-binaltorphimine decreases deprivation and opioid-induced feeding.
    Levine AS; Grace M; Billington CJ; Portoghese PS
    Brain Res; 1990 Nov; 534(1-2):60-4. PubMed ID: 1963567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE; Ho BY; Naeseth JS; Portoghese PS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
    Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
    Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.
    Makman MH; Dvorkin B; Crain SM
    Brain Res; 1988 Apr; 445(2):303-13. PubMed ID: 3370465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.